Neuronetics EVP Cory Anderson files Form 3 holdings
Neuronetics, Inc. executive Cory Anderson, EVP & Gen.
Rhea-AI Filing Summary
Neuronetics, Inc. executive Cory Anderson, EVP & Gen. Manager, Greenbrook, filed an initial statement of beneficial ownership. He reports direct holdings of the company’s common stock and performance restricted stock units that can deliver up to 15,000 and 18,335 shares at a $0.0000 exercise price. These PRSUs vest between December 31, 2026 and December 31, 2027, contingent on specified Cash Balance and Cash Flow Breakeven performance metrics and his continued service.
Positive
- None.
Negative
- None.
Filing Explained
The July 13 Form 3 records direct common-stock holdings and contingent equity awards, not a completed issuer share issuance or transfer.
The
Restricted stock units are described as contingent rights to receive one share of Neuronetics common stock, subject to the applicable vesting requirements. Table I lists 53,205 shares of common stock and six direct RSU awards for 13,336, 5,001, 3,334, 55,003, 136,933, and 150,000 shares, with the stated vesting dates in 2027.
Table II lists performance restricted stock units for 18,335 and 15,000 underlying common shares. The 18,335-share award begins vesting on
For existing common holders, the structural point is potential future share delivery under these awards; the filing does not state that the contingent shares have been issued.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| holding | Performance Restricted Stock Unit F8, F7 | -- | -- | -- |
| holding | Performance Restricted Stock Unit F8, F9 | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock F1 | -- | -- | -- |
| holding | Common Stock F2 | -- | -- | -- |
| holding | Common Stock F3 | -- | -- | -- |
| holding | Common Stock F4 | -- | -- | -- |
| holding | Common Stock F5 | -- | -- | -- |
| holding | Common Stock F6 | -- | -- | -- |
Footnotes (9)
- F1. Represents a restricted stock unit ("RSU") award that vests on February 5, 2027, subject to the Reporting Person's continuous service with the Issuer or its affiliates through such date. Each RSU represents a contingent right to receive one share of the Issuer's common stock.
- F2. Represents a RSU award that vests on February 28, 2027, subject to the Reporting Person's continuous service with the Issuer or its affiliates through such date. Each RSU represents a contingent right to receive one share of the Issuer's common stock.
- F3. Represents a RSU award that vests on March 28, 2027, subject to the Reporting Person's continuous service with the Issuer or its affiliates through such date. Each RSU represents a contingent right to receive one share of the Issuer's common stock.
- F4. Represents a RSU award that vests in two equal annual installments beginning on February 24, 2027, in each case subject to the Reporting Person's continuous service with the Issuer or its affiliates through such date. Each RSU represents a contingent right to receive one share of the Issuer's common stock.
- F5. Represents a RSU award that vests on June 30, 2027, subject to the Reporting Person's continuous service with the Issuer or its affiliates through such date. Each RSU represents a contingent right to receive one share of the Issuer's common stock.
- F6. Represents a RSU award that vests in three equal annual installments beginning on February 23, 2027, in each case subject to the Reporting Person's continuous service with the Issuer or its affiliates through such date. Each RSU represents a contingent right to receive one share of the Issuer's common stock.
- F7. Represents a performance restricted stock unit ("PRSU") award granted on February 24, 2025 and vesting beginning on December 31, 2026, subject to satisfaction of the applicable performance metrics and continuous service of the Reporting Person through such date. The performance metrics are as follows: (i) 50% of the award will be attained if the Issuer achieves Cash Balance (as defined in the applicable PRSU grant notice) for the fiscal year ended 2026 and (ii) 50% of the award will be attained if the Issuer achieves Cash Balance for the fiscal year ended 2027.
- F8. Each PRSU represents a contingent right to receive one share of the Issuer's common stock.
- F9. Represents a PRSU award granted on October 29, 2025 and vesting on December 31, 2026, subject to satisfaction of the applicable performance metrics and continuous service of the Reporting Person through such date. The performance metrics are as follows: the award will be attained if the Issuer achieves Cash Flow Breakeven (as defined in the applicable PRSU grant notice) for the fiscal quarter ended September 30, 2026.
Key Figures
Key Terms
restricted stock unit financial
performance restricted stock unit financial
Cash Balance financial
Cash Flow Breakeven financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What does Neuronetics (STIM) disclose about Cory Anderson in this Form 3?
What are the vesting dates for Cory Anderson’s Neuronetics (STIM) performance RSUs?
Which performance metrics affect Cory Anderson’s PRSUs at Neuronetics (STIM)?
Are Cory Anderson’s Neuronetics (STIM) RSU and PRSU awards contingent on continued service?
AI-generated analysis. How Rhea-AI works. Not financial advice.